This work reveals a novel underlying mechanism, SOX4-HDAC1 axis, for stemness maintenance of human cancer and suggests that HDAC1 inhibition should be an effective precision therapeutic strategy for eradicating SOX4-drived human CSCs. This evidence concerns the gene SOX4 and cancer.